Product defects and liability claims
Flow plates are developed in close cooperation with customers, so faults can lead to damages and reputational harm.
- Scope
- Customer-specific development and product quality
- Materiality
- high
Cell Impact
Cell Impact is a Swedish industrial technology company that develops and manufactures customized metal flow plates for fuel cells and electrolyzers. Its business is built around proprietary metal-forming technology and customer-specific development, with operations centered in Sweden and a subsidiary in Japan plus local presence in Germany.
| % | |
|---|---|
| Flow plates for fuel cells | 45% Metal plates used in fuel cell stacks to support electrochemical power generation. |
| Flow plates for electrolyzers | 35% Metal plates used in electrolyzers for hydrogen production from electricity and water. |
| Customer-specific development | 15% Engineering and development work performed jointly with customers on tailored solutions. |
| Other industrial metal processing | 5% Use of the forming technology in more mature industrial applications beyond hydrogen. |
Cell Impact sells primarily to industrial customers developing or scaling fuel cells and electrolyzers, where the flow...
- Fuel cell manufacturersprimary
Buy customized flow plates for fuel cell stacks and co-develop specifications for performance and manufacturability.
- Electrolyzer manufacturersprimary
Buy flow plates used in electrolyzers for hydrogen production and value scalable, cost-efficient production methods.
- Industrial technology customerssecondary
Buy customized metal processing solutions for mature industrial applications where the forming technology can be applied.
- Development partnerssecondary
Collaborate on product development, testing, and technical validation before volume production.
Cell Impact is headquartered and manufactures in Karlskoga, Sweden, which is the center of its production and...
- •Head office and production facility in Karlskoga, Sweden
- •Subsidiary in Japan supports Asian customer relationships
- •Local presence in Germany supports European industrial demand
- •International sales and sourcing create FX exposure
- •Hydrogen markets are global, so customer location matters
Cell Impact’s strategy is to commercialize its Cell Impact Forming™ technology by scaling production of flow plates for...
01
Commercialize flow plate manufacturingmedium-term
Volume production is central to making hydrogen components economically viable.
02
Expand production capacity and efficiencyshort-term
Higher throughput and lower unit cost are needed to serve industrial customers at scale.
03
Broaden use cases beyond hydrogenmedium-term
Mature industrial segments can provide additional demand and reduce dependence on hydrogen adoption timing.
Cell Impact is exposed to development, execution, and market-adoption risk because its products are often supplied...
Hydrogen market adoption risk
Demand depends on the pace of fuel cell and electrolyzer deployment, which can be affected by policy and market timing.
- Scope
- Fuel cell and electrolyzer end markets
- Materiality
- high
Financing risk
The company must secure short- and long-term funding to support development and production scaling.
- Scope
- Capital-intensive industrial technology business
- Materiality
- high
Foreign exchange risk
Sales and purchases in foreign currencies create translation and transaction exposure versus SEK.
- Scope
- International operations
- Materiality
- medium
Key-person risk
A small organization depends on specialized technical and managerial knowledge.
- Scope
- Engineering and leadership team
- Materiality
- medium
Revenue recognition on projects and services
Affects timing of reported sales and margin
Inventory and work in progress
Affects operating income and comparability across quarters
Provisions and contingent liabilities
Affects expenses, liabilities, and equity
Impairment of intangible and tangible assets
Could materially affect carrying values
Lease accounting
Affects balance sheet leverage and operating metrics
IMPACT BIOMEDICAL INC.
IBO · Pharmaceutical Preparations
CellaVision
CEVI.ST · Health Care
CellaVision is a global medical technology company specializing in the development and sale of advanced solutions for the routine analysis of blood and other body fluids.
Celldex Therapeutics, Inc.
CLDX · In Vitro & In Vivo Diagnostic Substances
CEL SCI CORP
CVM · Biological Products, (No Diagnostic Substances)
Cellectar Biosciences, Inc.
CLRB · Pharmaceutical Preparations
CalciMedica, Inc.
CALC · Pharmaceutical Preparations
: 11/08/2026